RhPSA prostate cancer vaccine: Phase I/II started

Cyto Pulse began a Swedish Phase I/II trial to evaluate intradermal pVAXrcPSAv53l in combination with electroporation in 18 patients for 12 months. The company jointly developed the vaccine with the K...